About embecta embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people ... Embecta Corporation Registered Shs When Issued NewsMORE Related ...

A webcast replay of the call will be available beginning at 11:00 a.m. ET on Nov 21, 2024, via the embecta investor relations website and archived on the website for one year. About embecta embecta is ...

On Monday, the S&P 500 eclipsed the coveted 6,000 mark, banking on the post-election rally. Donald Trump’s election victory ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Shares of Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Free Report) were down 9.6% on Friday after Canaccord Genuity Group lowered their price target on the stock from $57.00 to $56.00. Canaccord ...

Insulet stock soared out of a buy zone Friday after the insulin pump-maker "continued the beat-and-raise cadence it has seen in 2024." ...

Axon Enterprise ( AXON) was the best-performing stock in the S&P 500, with shares hitting an all-time high after the TASER ...

At about $69 per share, DexCom's stock isn't that far off its 52-week low of $62.34 ... for diabetics who aren't using ...

Insulet (Nasdaq:PODD) shares ticked up today on third-quarter results that came in well ahead of the consensus forecast.

Tandem Diabetes Care (TNDM) and Insulet (PODD) stocks draw outperform ratings at Bernstein as insulin pump makers prepare for ...

Commissions do not affect our editors' opinions or evaluations. Growth stocks refer to shares of companies that are expected to grow at rates significantly above the average for the stock market ...